589C80

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

1993

1993

The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to…

P. Rolan, J. E. Parker, +5 authors J. Posner
British journal of clinical pharmacology
1993

Corpus ID: 20617276

1. Tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid) interacts stoichiometrically with haemoglobin to increase… Expand

1992

1992

Substituted benzaldehydes (12C79 and 589C80) that stabilize oxyhaemoglobin also protect sickle cells against calcium‐mediated dehydration

P. C. Stone, G. Nash, J. Stuart
British journal of haematology
1992

Corpus ID: 27855371

Reversibly sickled cells from patients with homozygous sickle‐cell disease were prepared by Percoll–Isopaque density gradient… Expand